Clinical Trial Update: Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating neoadjuvant oxaliplatin-UFT radiotherapy for rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• UFT (tegafur-uracil) (tegafur-uracil)

Snippet

Sponsor: Sanofi | Conditions: Rectal Neoplasms | Phase 1, Phase 2 | Status: COMPLETED